Endovia Health Sciences, Inc.
EDVA· NYSE
Filed Nov 13, 2013 · 10-Q · 44 days after period end · 0001079974-13-000711
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Revenue | $141.85K | $89.65K |
| Net Income | -$11.16K | $3.00K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 13, 2013 · 44 d after period end